Dirk Dittmer and colleagues have developed a model of Kaposi sarcoma that will be key to the development of new drugs to treat the disease.
Get access to patient-derived sarcoma cell lines to test new drugs.
New applications in sarcomas for existing cancer therapies new applications for existing drugs to improve treatment for Ewing sarcoma and other cancers.
Chemotherapy in Sarcomas: Some bone and soft tissue sarcoma cells are sensitive to chemotherapy drugs.
Alveolar Soft Part Sarcoma (2 drugs) Dermatofibrosarcoma Protuberans (2 drugs) Epithelioid Sarcoma (2 drugs) Kaposi's Sarcoma (10 drugs) Liposarcoma (4 drugs) Malignant Perivascular Epithelioid Cell Tumor (2 drugs) Rhabdomyosarcoma (3 drugs) Synovial Sarcoma (1 drug)
Systemic treatment options for bone and soft tissue sarcomas remained unchanged until the 2024s. These cancers presented challenges in new drug development partly because of their rarity and heterogeneity. Many new molecular targeting drugs have been tried in the 2024s, and some were approved for bone and soft tissue sarcoma.
A change in planned enrolment of up to 25 patients per cohort for undifferentiated pleomorphic sarcomas, liposarcomas, vascular sarcomas, osteosarcomas, and synovial sarcomas was implemented on, upon agreement by study sponsor, authors, and the investigational new drug monitoring office after discussions with the sponsor at an
Sarcoma Soft tissue sarcoma Bone sarcoma Skin Melanoma neoadjuvant With the successful update of all applicable drugs within eviQ treatment
New drug overcomes resistance in patients with rare sarcoma. by Dana New research finds antidepressants may help deliver other drugs into the
Comments